Dr. Pravin Mishra
Chief Operating Officer, Oklahoma Pandemic Center of Innovation and Excellence
Dr. Pravin Mishra has contributed in extensive peer-reviewed research work at the National Cancer Institute, National Institutes of Health and Rutgers University. He is widely published in the areas of cancer care, precision medicine and emerging technologies.
In his role as the Chief Operating Officer at the OPCIE, Dr. Mishra is responsible for leading innovative scientific advancements in the state, collaborating with local and national partners, helping establish a nationally-competitive public health lab and working to fulfill the visionary mission that will become One Health Park campus. In his previous role as the Director of Clinical Translation Science Resource for The Ohio State University, Dr. Mishra contributed in developing multiple clinical trials, novel therapies and implemented system-wide clinical, translational and precision medicine programs. Coordinated in technology transfer, new business development, research center space designing/planning, capital purchases, strategy, and infrastructure development. Previously, as the founding Director of the Research and Development Center at Intermountain Healthcare, he contributed to the big health-data-based consortium (as noted by Joe Biden during his Moon-Shot speech), designed and established a world-class accredited clinical genomics facility and R&D laboratory, facilitated translational research (bench-to-bedside) and advanced precision medicine efforts. His contribution in molecular tumor board and system-wide implementation of oncology precision medicine, one of the first in the world, was featured in a dedicated Harvard Business School case study.
He is a patent holder for improved antitumoral treatment, use of stem cells for wound healing and anti-cancer therapy, Reconstituted tumor microenvironment for anticancer drug development, Integrated Genomics pathway identification in melanoma genesis; implications in combination therapy and Induction of Protein Downstream of Internal Ribosomal Entry Site (IRES) by antifolates treatment. Dr. Mishra is a founding member of two international non-profit organizations and a few bio pharma start-up.
Dr. Mishra was invited in 2018 to attend GES (global entrepreneur Summit) as a US delegate, sharing insights on precision medicine and emerging cancer solutions. He has organized and conducted Cancer Day events domestically and internationally, and led multiple-precision medicine and AI thought leader programs.
Dr. Mishra earned his PhD in Molecular Medicine from George Washington University and MBA in strategy and leadership from The Ohio State University.
Dr. Anil Kaul
Director of Clinical Laboratory
Formally trained as a physician, dentist and public health, Dr. Anil Kaul is a physician-scientist working in the field of infectious diseases for more than 25 years. Currently, he serves as a Clinical Professor & Program Director for Global Health at Oklahoma State University - Center for Health Sciences (OSU-CHS), where he teaches graduate courses related to global health and emerging infections. In addition, he directs the Infectious Diseases Clinical laboratory at OSU-CHS which he established in 2009.
At the beginning of the current pandemic, Dr. Kaul volunteered to establish and direct the high complexity diagnostic laboratory for COVID-19 testing for the Oklahoma State by converting the animal diagnostic laboratory at Oklahoma State University into human diagnostic laboratory and later directed the OSU Diagnostic laboratory for COVID-19.
Dr. Kaul has served as a technical Consultant for the Defense Threat Reduction Agency's (DTRA) Cooperative Biological Engagement Program (CBEP) and as Senior Public Health Advisor in Iraq with the US Department of State, where he worked closely with multiple US agencies - the US Military, DoS and USAID to assess basic healthcare needs of Iraq and started a telemedicine link between rural Iraqi clinics and major Baghdad hospitals with academic health centers in India and USA. He has also served as a consultant for USAID Funded projects using health systems approach and proven quality improvement methods to achieve rapid improvements in HIV/AIDS and TB screening, service delivery, increasing awareness on infection control and treatment adherence. As a Senior Health Policy Analyst with the Health Technology Advisory Committee for the state of Minnesota, he evaluated healthcare programs, provided technology assessments for policy makers, providers and consumers.
He has published 80 scientific papers with more than 150 presentations. He has been awarded multiple U.S. Patents and received a number of recognitions including the Secretary’s Expeditionary Service Award from the US Department of State, Lifetime Achievement Award at the Global Healthcare Summit, and the Sony-Walmart’s “Science Achiever of the year” award.